search
Back to results

Telephone Services for Participation in Colorectal Cancer Screening (ColoPhone)

Primary Purpose

Participation Rate, Patient

Status
Unknown status
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Telephone recruitment to screening colonoscopy
Combined methods recruitment to screening colonoscopy
Sponsored by
Maria Sklodowska-Curie National Research Institute of Oncology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Participation Rate, Patient focused on measuring colorectal cancer screening, screening colonoscopy, screening participation, telephone services

Eligibility Criteria

55 Years - 64 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • population included to invitation within Polish population based Colorectal cancer Screening Program (PCSP)

    • 55-64 of age
    • no history of CRC
    • no history of screening colonoscopy within PCSP
  • adress of residence near (not further than 40 kilometers) local PCSP centers (selected for the study based on population density)

Exclusion Criteria:

  • none

Sites / Locations

  • The Maria Sklodowska-Curie National Research Institute of Oncology

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Control group

Call Center

Combined

Arm Description

Invitation letter and reminder letter to screening colonoscopy

Telephone recruitment by motivational conversation and colonoscopy appointment

Non responders to invitation and reminder letter will be recruited by telephone conversation

Outcomes

Primary Outcome Measures

Participation rate to screening colonoscopy within PCSP per recruitment strategy
The percentage of study participants who underwent screening colonoscopy relative to all PCSP participants to whom the invitation was sent in a given group during the observation period (intention-to-screen analysis)

Secondary Outcome Measures

Response rate to invitation to screening colonoscopy
Contact with local PCSP center

Full Information

First Posted
April 10, 2020
Last Updated
April 14, 2020
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborators
Ministry of Health, Poland, Screening up, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT04348058
Brief Title
Telephone Services for Participation in Colorectal Cancer Screening
Acronym
ColoPhone
Official Title
Telephone Services for Participation Improvement in Colorectal Cancer Screening: a Randomized Health Services Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
August 20, 2020 (Anticipated)
Primary Completion Date
July 30, 2021 (Anticipated)
Study Completion Date
August 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborators
Ministry of Health, Poland, Screening up, Poland

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A multicentre randomized health services study within the population-based primary colonoscopy screening program (PCSP) in Poland. Individuals, aged 55-60 years, willl be randomized in a 1:1:1 ratio to arms: (1) Invitation by post, (2) Call Center or (2) Combined invitation methods. The primary outcome measure is rate of participation in screening colonoscopy. The sample size of 6 300 participants will detect 3 to 5 percentage point differences (depending on the arms comparison) in participation rate between groups with 80% power and significance level 0.05, using Ochran-Mantel-Haenszel test.
Detailed Description
This randomized health services study will be performed within national population-based screening program (PCSP) in Poland, including its population, infrastructure and database system. Individuals aged 55-64 years old, included in PCSP willl be randomly assigned (in 1:1:1 ratio, stratified by gender, age, place of residence) to study arms and invited to screening colonoscopy to local PSCP centers. Invitation process by post in Control group (1) and partially in Combined group (3) - will be performed by coordinating PCSP center (practice as usual). Recruitment by telephone conversation in Call Center group (2) and partially in Combined group (3) - will be performed by Screening Up call center company. Colonoscopies will be performed in 6 selected PCSP centers. The sample size of 2,100 participants per group (350 participants from each group in each center, assuming 5% drop out and access to telephone numbers of 30% participants in relevant arms; calculation is based on a 95% confidence interval +/- 5% error probability) was calculated to detect a difference in participation rate of 15% in control group (based on PCSP participation rate in 2019) vs. 18.7% in Call Center group vs 25% in Combined Invitation group (0.025 significance level with 80% power). The difference was calculated for the Cochran-Mantel-Haenszel test, assuming that the initial reporting in the control group will be as high as it was in 2019. Differences in participation rate to screening colonoscopy between the study groups and the control group will be performed using Ochran-Mantel-Haenszel test (two-sided analysis), taking into account initial differences between rates at the significance level of 0.05. The Principal Investigator of the study asked the Bioethical Committee with a request to release participants from signing of informed consent form to participation in the study, as they take part in a nationwide PSCP, financed by Ministry of Health in Poland - the study character is the Randomized Health Services Study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Participation Rate, Patient
Keywords
colorectal cancer screening, screening colonoscopy, screening participation, telephone services

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
prospective
Masking
None (Open Label)
Allocation
Randomized
Enrollment
6300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Invitation letter and reminder letter to screening colonoscopy
Arm Title
Call Center
Arm Type
Experimental
Arm Description
Telephone recruitment by motivational conversation and colonoscopy appointment
Arm Title
Combined
Arm Type
Experimental
Arm Description
Non responders to invitation and reminder letter will be recruited by telephone conversation
Intervention Type
Behavioral
Intervention Name(s)
Telephone recruitment to screening colonoscopy
Intervention Description
Utilisation of dedicated call center for recruitment to screening program instead of traditional, paper invitation
Intervention Type
Behavioral
Intervention Name(s)
Combined methods recruitment to screening colonoscopy
Intervention Description
Utilisation of dedicated call center for recruitment to screening program in participants, who did not respond to traditional, paper invitation
Primary Outcome Measure Information:
Title
Participation rate to screening colonoscopy within PCSP per recruitment strategy
Description
The percentage of study participants who underwent screening colonoscopy relative to all PCSP participants to whom the invitation was sent in a given group during the observation period (intention-to-screen analysis)
Time Frame
26 weeks after intervention
Secondary Outcome Measure Information:
Title
Response rate to invitation to screening colonoscopy
Description
Contact with local PCSP center
Time Frame
26 weeks after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: population included to invitation within Polish population based Colorectal cancer Screening Program (PCSP) 55-64 of age no history of CRC no history of screening colonoscopy within PCSP adress of residence near (not further than 40 kilometers) local PCSP centers (selected for the study based on population density) Exclusion Criteria: none
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marek Bugajski, PhD
Phone
+48 22 546 23 28
Email
marek.bugajski@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Małgorzata Pisera
Phone
+48 22 546 23 28
Email
mpisera@gmail.com
Facility Information:
Facility Name
The Maria Sklodowska-Curie National Research Institute of Oncology
City
Warsaw
State/Province
Mazovian
ZIP/Postal Code
02-781
Country
Poland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marek Bugajski, PhD
Phone
+48 22 546 2328
Email
marek.bugajski@gmail.com
First Name & Middle Initial & Last Name & Degree
Małgorzata Pisera
Phone
+48 22 546 23 28
Email
mpisera@gmail.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
23485231
Citation
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
Results Reference
background
PubMed Identifier
23212726
Citation
European Colorectal Cancer Screening Guidelines Working Group; von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Camargo Cancela M, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinas JA, Faivre J, Faulds Wood L, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Madai S, Marinho J, Maucec Zakotnik J, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Peris Tuser M, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Tornberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51-9. doi: 10.1055/s-0032-1325997. Epub 2012 Dec 4.
Results Reference
background
PubMed Identifier
28600072
Citation
Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 Jul;153(1):307-323. doi: 10.1053/j.gastro.2017.05.013. Epub 2017 Jun 9.
Results Reference
background
PubMed Identifier
26517847
Citation
Kaminski MF, Kraszewska E, Rupinski M, Laskowska M, Wieszczy P, Regula J. Design of the Polish Colonoscopy Screening Program: a randomized health services study. Endoscopy. 2015 Dec;47(12):1144-50. doi: 10.1055/s-0034-1392769. Epub 2015 Oct 30.
Results Reference
background
PubMed Identifier
23663511
Citation
Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, Guasticchi G, Giorgi Rossi P; Methods to increase participation Working Group. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health. 2013 May 13;13:464. doi: 10.1186/1471-2458-13-464.
Results Reference
background
PubMed Identifier
31685010
Citation
Goodwin BC, Ireland MJ, March S, Myers L, Crawford-Williams F, Chambers SK, Aitken JF, Dunn J. Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis. Syst Rev. 2019 Nov 4;8(1):257. doi: 10.1186/s13643-019-1170-x.
Results Reference
background

Learn more about this trial

Telephone Services for Participation in Colorectal Cancer Screening

We'll reach out to this number within 24 hrs